Jagot J[au] - Search Results

Year	Number of Results
1987	1
1989	1
1996	1
1998	3
1999	1
2002	1
2003	1
2004	1
2006	1
2012	1
2013	1
2021	0

1

[Targeted agents in the treatment of lung cancer].

Staudacher L, Teixeira L, Kempf E, Rousseau-Bussac G, Jouveshomme S, Cohen R, Beuzelin C, Jagot JL, Salmeron S, Trédaniel J. Staudacher L, et al. Among authors: jagot jl. Pathol Biol (Paris). 2012 Aug;60(4):246-53. doi: 10.1016/j.patbio.2012.05.011. Epub 2012 Jun 26. Pathol Biol (Paris). 2012. PMID: 22743094 Review. French.

2

Primary pulmonary hypertension associated with the use of fenfluramine derivatives.

Simonneau G, Fartoukh M, Sitbon O, Humbert M, Jagot JL, Hervé P. Simonneau G, et al. Among authors: jagot jl. Chest. 1998 Sep;114(3 Suppl):195S-199S. doi: 10.1378/chest.114.3_supplement.195s. Chest. 1998. PMID: 9741568 Review.

3

The ETHICA study (part I): elderly's thoughts about intensive care unit admission for life-sustaining treatments.

Philippart F, Vesin A, Bruel C, Kpodji A, Durand-Gasselin B, Garçon P, Levy-Soussan M, Jagot JL, Calvo-Verjat N, Timsit JF, Misset B, Garrouste-Orgeas M. Philippart F, et al. Among authors: jagot jl. Intensive Care Med. 2013 Sep;39(9):1565-73. doi: 10.1007/s00134-013-2976-y. Epub 2013 Jun 14. Intensive Care Med. 2013. PMID: 23765236

4

[Pleural trichomoniasis due to trichomonas tenax].

Porcheret H, Maisonneuve L, Estève V, Jagot JL, Le Pennec MP. Porcheret H, et al. Among authors: jagot jl. Rev Mal Respir. 2002 Feb;19(1):97-9. Rev Mal Respir. 2002. PMID: 17546821 French.

5

[Home chemotherapy for lung cancer: a five year retrospective study].

Virally J, Fouques Duparc V, Lazzerini C, Boiron C, Jagot JL, Mathieu M. Virally J, et al. Among authors: jagot jl. Rev Mal Respir. 2003 Nov;20(5 Pt 1):683-9. Rev Mal Respir. 2003. PMID: 14631247 French.

6

[Epidemiology and delays in the management of 355 patients with lung cancer].

Virally J, Choudat L, Chebbo M, Sartene R, Jagot JL, Elhadad A, Brassier D, Habib E, Chalmin B, Boiron C, Bienvenu L, Duperrin V, Mathieu M. Virally J, et al. Among authors: jagot jl. Rev Mal Respir. 2006 Feb;23(1 Pt 1):43-8. doi: 10.1016/s0761-8425(06)71461-9. Rev Mal Respir. 2006. PMID: 16604025 French.

7

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

Sitbon O, Humbert M, Jagot JL, Taravella O, Fartoukh M, Parent F, Herve P, Simonneau G. Sitbon O, et al. Among authors: jagot jl. Eur Respir J. 1998 Aug;12(2):265-70. doi: 10.1183/09031936.98.12020265. Eur Respir J. 1998. PMID: 9727772 Free article.

8

Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.

Humbert M, Sanchez O, Fartoukh M, Jagot JL, Le Gall C, Sitbon O, Parent F, Simonneau G. Humbert M, et al. Among authors: jagot jl. Eur Respir J. 1999 Jun;13(6):1351-6. doi: 10.1183/09031936.99.13613579. Eur Respir J. 1999. PMID: 10445611 Free article. Clinical Trial.

9

[Pulmonary nocardiosis and broncho-oesophageal fistula in a patient infected with HIV].

Luketombunga JC, Virally J, Jagot JL, Elhadad A, Lebarbier C, Mathieu M. Luketombunga JC, et al. Among authors: jagot jl. Rev Mal Respir. 2004 Feb;21(1):147-51. doi: 10.1016/s0761-8425(04)71247-4. Rev Mal Respir. 2004. PMID: 15260050 French.

10

Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin).

Humbert M, Sanchez O, Fartoukh M, Jagot JL, Sitbon O, Simonneau G. Humbert M, et al. Among authors: jagot jl. Chest. 1998 Jul;114(1 Suppl):80S-82S. doi: 10.1378/chest.114.1_supplement.80s. Chest. 1998. PMID: 9676646 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results